Trial
NCT06068543
Reducing Frailty for Older Cancer Survivors Using Supplements II
Phase IISUSPENDEDOTHER/UNKNOWNConfidence: LOW
Sponsor
University of Rochester
Collaborators
—
Condition
Frailty
Intervention
Epigallocatechin-3-Gallate (EGCG)
Why stopped
The study has been suspended by the IRB pending review of a study-related issue
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2026-06-26